医药资本是个圈。。。

医药财经
Jan 18

生物医药资本圈,已形成一个由顶级产业集团(如药明系等)与大型财务资本(如维梧、高瓴等)共同主导的、多维度交织的生态系统。药明系勾勒出一个超越传统商业的轮廓:药明康德在出售资产套现近60亿元后,药明合联以31亿收购东曜药业。药明系不仅是最大的医药研发服务提供商(CXO),还通过旗下投资平台,以有限合伙人(LP)身份设立或参投数十只生物医药基金,直接投资孵化数百家小型生物科技公司(Biotech)。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10